BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22455388)

  • 1. Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells.
    Elizalde C; Fernández-Rueda J; Salcedo JM; Dorronsoro A; Ferrin I; Jakobsson E; Trigueros C
    Stem Cells Dev; 2012 Sep; 21(14):2581-91. PubMed ID: 22455388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
    Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
    Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor.
    Zimran E; Papa L; Djedaini M; Patel A; Iancu-Rubin C; Hoffman R
    Stem Cells Transl Med; 2020 Apr; 9(4):531-542. PubMed ID: 31950644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells.
    De Felice L; Tatarelli C; Mascolo MG; Gregorj C; Agostini F; Fiorini R; Gelmetti V; Pascale S; Padula F; Petrucci MT; Arcese W; Nervi C
    Cancer Res; 2005 Feb; 65(4):1505-13. PubMed ID: 15735039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo.
    Lam YM; Chan YF; Chan LC; Ng RK
    Int J Hematol; 2017 Jan; 105(1):37-43. PubMed ID: 27531147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells.
    Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid.
    Papa L; Djedaini M; Hoffman R
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31033947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
    Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
    Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.
    Bug G; Gül H; Schwarz K; Pfeifer H; Kampfmann M; Zheng X; Beissert T; Boehrer S; Hoelzer D; Ottmann OG; Ruthardt M
    Cancer Res; 2005 Apr; 65(7):2537-41. PubMed ID: 15805245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial CD34+ cell-enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon ex vivo expansion.
    Andrade PZ; da Silva CL; dos Santos F; Almeida-Porada G; Cabral JM
    J Cell Biochem; 2011 Jul; 112(7):1822-31. PubMed ID: 21400571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic and molecular signatures of cord blood CD34(+) cells treated with histone deacetylase inhibitors.
    Gajzer D; Ross J; Winder L; Navada S; Zhang W; Silverman L; Chaurasia P
    Vox Sang; 2016 Jan; 110(1):79-89. PubMed ID: 26084882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibition enhances self renewal and cardioprotection by human cord blood-derived CD34 cells.
    Burba I; Colombo GI; Staszewsky LI; De Simone M; Devanna P; Nanni S; Avitabile D; Molla F; Cosentino S; Russo I; De Angelis N; Soldo A; Biondi A; Gambini E; Gaetano C; Farsetti A; Pompilio G; Latini R; Capogrossi MC; Pesce M
    PLoS One; 2011; 6(7):e22158. PubMed ID: 21789227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histone Deacetylase Inhibitors in the in Vitro Expansion of Hematopoietic Stem Cells].
    Chen M; Zhuang JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):109-115. PubMed ID: 33663671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of Erythropoietic Differentiation in Hematopoietic Stem Cells by SOCS3 Knock-Down.
    Liu YX; Dong X; Gong F; Su N; Li SB; Zhang HT; Liu JL; Xue JH; Ji SP; Zhang ZW
    PLoS One; 2015; 10(8):e0135259. PubMed ID: 26252772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells.
    da Silva CL; Gonçalves R; dos Santos F; Andrade PZ; Almeida-Porada G; Cabral JM
    J Tissue Eng Regen Med; 2010 Feb; 4(2):149-58. PubMed ID: 19937912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of P16 cell cycle inhibitor in human cord blood CD34+ expanded cells following co-culture with bone marrow-derived mesenchymal stem cells.
    Oodi A; Noruzinia M; Habibi Roudkenar M; Nikougoftar M; Soltanpour MS; Khorshidfar M; Amirizadeh N
    Hematology; 2012 Nov; 17(6):334-40. PubMed ID: 22989929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions.
    Seet LF; Teng E; Lai YS; Laning J; Kraus M; Wnendt S; Merchav S; Chan SL
    Eur J Haematol; 2009 Feb; 82(2):124-32. PubMed ID: 19067743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent.
    Mishima S; Nagai A; Abdullah S; Matsuda C; Taketani T; Kumakura S; Shibata H; Ishikura H; Kim SU; Masuda J
    Eur J Haematol; 2010 Jun; 84(6):538-46. PubMed ID: 20088916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
    Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
    Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.